Cc1cc(C)cc(C(O)c2nc(-c3cccc(C(F)(F)F)c3)c[nH]2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?